Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same ...

Revenues increased 34% compared to the previous quarter ended September 30, 2024; and exceeded $1 millionReceived CE Mark for LungFit PH® in ...

Medical device company Zimmer Biomet (NYSE:ZBH) met Wall Street’s revenue expectations in Q4 CY2024, with sales up 4.3% year ...

Stratasys' stock surged over 20% after the company released preliminary fourth quarter results, even though results were ...

The healthcare industry is poised for growth driven by aging populations, technological advancements, and increased ...

Altria Group reported robust Q4 earnings, driven by NJOY's alternative products growth. Click here to see why MO stock is a ...

MO stock, with 41% returns since the beginning of 2024, has outperformed the S&P 500 index, up 27%. This can be attributed to ...

On the earnings call, the Richmond, Virginia-based company did address the illicit e-vapor market. Gifford told investors ...

Option activity in these three fallen angel stocks has ticked up lately, and the shares could be ready to follow along for ...

It’s critical to understand what a digitally savvy HCP is in 2025 and what’s impeding pharma's communications with this ...